CIK 0001528287 · <br>Emerging growth company
NeuroPace Inc
Sign in to watch- Ticker
- NPCE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 223550230
- Phone
- 6502372700
- Business address
- 455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-21 | Fischer Frank M Director | Grant or award | +2,281 | $10.41 | $24K | 589,531 |
| 2025-06-20 | Williams Patrick F. Chief Financial Officer | Grant or award | +51,850 | 51,850 | ||
| 2025-06-20 | Williams Patrick F. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +87,950 | 87,950 | ||
| 2025-06-06 | Ryan Renee Director | Grant or award · Stock Option (right to buy) | +8,745 | 8,745 | ||
| 2025-06-06 | LACOB JOSEPH Director | Grant or award · Stock Option (right to buy) | +8,745 | 8,745 | ||
| 2025-06-06 | Kumar Rakhi Director | Grant or award · Stock Option (right to buy) | +8,745 | 8,745 | ||
| 2025-06-06 | Huennekens R Scott Director | Grant or award · Stock Option (right to buy) | +8,745 | 8,745 | ||
| 2025-06-06 | Geiger Uri Director | Grant or award · Stock Option (right to buy) | +8,745 | 8,745 | ||
| 2025-06-06 | Fischer Frank M Director | Grant or award · Stock Option (right to buy) | +8,745 | 8,745 | ||
| 2025-06-06 | Andrade Lisa Director | Grant or award · Stock Option (right to buy) | +8,745 | 8,745 | ||
| 2025-06-03 | Kuhn Rebecca CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,337 | $13.54 | $18K | 131,613 |
| 2025-06-03 | Morrell Martha CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,338 | $13.54 | $18K | 85,943 |
| 2025-05-27 | Becker Joel CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −1,126 | $12.66 | $14K | 105,338 |
| 2025-05-27 | Kuhn Rebecca CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −357 | $12.66 | $5K | 132,950 |
| 2025-05-27 | Morrell Martha CHIEF MEDICAL OFFICER | Shares withheld for taxes | −357 | $12.66 | $5K | 87,281 |
| 2025-05-20 | Kuhn Rebecca CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −3,051 | $17.99 | $55K | 133,307 |
| 2025-05-20 | Morrell Martha CHIEF MEDICAL OFFICER | Shares withheld for taxes | −3,051 | $17.99 | $55K | 87,638 |
| 2025-05-14 | ORBIMED ADVISORS LLC 10% owner | Sale | −134,136 | $15.83 | $2.1M | 3,272,199 |
| 2025-05-14 | ORBIMED ADVISORS LLC 10% owner | Sale | −34,000 | $15.94 | $542K | 3,238,199 |
| 2025-04-22 | Kuhn Rebecca CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −237 | $10.94 | $3K | 136,358 |
Page 4 of 12 · 239 trades